RxDoctor Payments DataLook up a doctor →

Jill Langer, MD

Diagnostic Radiology · Philadelphia, PANPI 1003844192

Payments from drug & device makers

$895,416in general payments, 2019–2025

Across 583 payments — averaging $1535.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$681K
  • Pfizer$85K
  • Boehringer Ingelheim$71K
  • Seagen Inc.$45K
  • Boehringer Ingelheim International GmbH$14K
$1,200,638in research payments, 2019–2025

Across 92 payments — averaging $13,050 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$1.1M
  • Boehringer Ingelheim$35K
  • Regeneron$9K
  • Boehringer Ingelheim International GmbH$4K
  • Genentech, Inc.$4K

What the payments were for

  • Consulting fees$895,416100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck529$681,351
Pfizer24$84,990
Boehringer Ingelheim17$70,555
Seagen Inc.11$44,835
Boehringer Ingelheim International GmbH2$13,685

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$895,416 in reported general payments places this provider in the 95th percentile of 1,665 diagnostic radiology providers in Pennsylvania.

See all diagnostic radiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$56,503
Medicare patients
954
Services billed
1,383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →